UB Paderborn / Katalog / Suche / in CDI

Determine safety of outpatient chemotherapy and autotransplants using refrigerated, non‐frozen grafts in persons with multiple sclerosis

Clinical transplantation, 2019-06, Vol.33 (6), p.e13567-n/a

2019

Volltextzugriff (PDF)

Prevalence of the t(11; 14)(q13; q32) immunoglobulin H/CCND1 in Mexican mestizos with multiple myeloma: A single institution experience

Iraqi journal of hematology, 2024-02, Vol.13 (1), p.150-153

2024

Volltextzugriff (PDF)

Treatment of Persons with Multiple Myeloma in Underprivileged Circumstances: Real-World Data from a Single Institution

Acta haematologica, 2020, Vol.143 (6), p.552-558

2020

Volltextzugriff (PDF)

Non-alcoholic fatty liver disease and thrombocytopenia IV: its association with granulocytopenia

Hematology, Transfusion and Cell Therapy, 2022-10, Vol.44 (4), p.491-496

2022

Volltextzugriff (PDF)

Up to half of patients diagnosed with chronic lymphocytic leukemia in México may not require treatment

Hematology (Luxembourg), 2020-01, Vol.25 (1), p.156-159

2020

Volltextzugriff (PDF)

Long-term results of the treatment of Hodgkin’s lymphoma in a resource-constrained setting: Real-world data from a single center

World journal of clinical oncology, 2021-09, Vol.12 (9), p.800-807

2021

Volltextzugriff (PDF)

Patient-Reported-Outcomes and Safety of Autologous Stem Cell Transplantation in Multiple Sclerosis: A Single Center Experience with the "Mexican Method" in 1300 Persons

Blood, 2022-11, Vol.140 (Supplement 1), p.1178-1179

2022

Volltextzugriff (PDF)

Secondary malignancies after allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning and outpatient conduction

Hematology (Luxembourg), 2014-12, Vol.19 (8), p.435-440

2014

Volltextzugriff (PDF)

Reduced-intensity stem cell allografting for PNH patients in the eculizumab era: The Mexican experience

Hematology (Luxembourg), 2015-06, Vol.20 (5), p.263-266

2015

Volltextzugriff (PDF)

IKAROS Gene Deleted B-Cell Acute Lymphoblastic Leukemia in Mexican Mestizos: Observations in Seven Patients and a Short Review of the Literature

Revista de investigacion clinica, 2016-07, Vol.68 (4), p.210-214

2016

Volltextzugriff (PDF)

Long-Term Results of the Treatment of Adolescents and Adults with Acute Lymphoblastic Leukemia with a Pediatric-Inspired Regimen Delivered on an Outpatient Basis: A Single Institution Experience

Blood, 2022-11, Vol.140 (Supplement 1), p.11590-11591

2022

Volltextzugriff (PDF)

Simultaneous romiplostin, eltrombopag, and prednisone were successful in severe thrombocytopenia of Evans syndrome refractory to hydrocortisone, splenectomy, intravenous IgG, and rituximab

Hematology (Luxembourg), 2013-05, Vol.18 (3), p.175-177

2013

Volltextzugriff (PDF)

In pursuit of the graft-versus-myeloma effect: A single institution experience

Hematology (Luxembourg), 2013-03, Vol.18 (2), p.89-92

2013

Volltextzugriff (PDF)

ALL-422 Therapy of Childhood Acute Lymphoblastic Leukemia (ALL) in Resource-Poor Geospaces

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S251-S251

2023

Volltextzugriff (PDF)

CML-416 Allogeneic Hematopoietic Stem Cell Transplantation in Chronic Myelogenous Leukemia in the Tyrosine-Kinase Inhibitors Era: A Single Institution Experience

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S341-S341

2023

Volltextzugriff (PDF)

ALL-419 Can Doses of Post-Transplantation Cyclophosphamide in Haploidentical Stem Cell Allografts Be Reduced?

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S250-S251

2023

Volltextzugriff (PDF)

POSTER: ALL-422 Therapy of Childhood Acute Lymphoblastic Leukemia (ALL) in Resource-Poor Geospaces

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S152-S152

2023

Volltextzugriff (PDF)

POSTER: ALL-419 Can Doses of Post-Transplantation Cyclophosphamide in Haploidentical Stem Cell Allografts Be Reduced?

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S151-S151

2023

Volltextzugriff (PDF)

POSTER: CML-416 Allogeneic Hematopoietic Stem Cell Transplantation in Chronic Myelogenous Leukemia in the Tyrosine-Kinase Inhibitors Era: A Single Institution Experience

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S176-S176

2023

Volltextzugriff (PDF)

POOR HEMOPOIETIC STEM CELL MOBILIZERS IN MULTIPLE MYELOMA : A SINGLE INSTITUTION EXPERIENCE

Mediterranean journal of hematology and infectious diseases, 2010-06, Vol.2 (2), p.e2010016-e2010016

2010

Volltextzugriff (PDF)

Reporte de la Primera Reunión Nacional de Consenso para la Inmunofenotipificación de Leucemias Agudas

Gaceta médica de México, 2019, Vol.155 (1), p.20-29

2019

Volltextzugriff (PDF)

Modifications to the “Classical” Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis: Efficacy and Safety Study of a Less Toxic Approach Which Improves the Neurological Condition. a Mexican Perspective

Blood, 2017-12, Vol.130, p.3290-3290

2017

Volltextzugriff (PDF)

Subsequent Malignant Neoplasms after Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning and Outpatient Conduction

Biology of blood and marrow transplantation, 2014-02, Vol.20 (2), p.S249-S250

2014

Volltextzugriff (PDF)

POOR HEMOPOIETIC STEM CELL MOBILIZERS IN MULTIPLE MYELOMA : A SINGLE INSTITUTION EXPERIENCE

Mediterranean journal of hematology and infectious diseases, 2010-05, Vol.2 (2), p.e2010016-e2010016

2010

Volltextzugriff (PDF)

In Pursuit of the Graft Versus Myeloma Effect: A Single Institution Experience

Biology of blood and marrow transplantation, 2013-02, Vol.19 (2), p.S238-S238

2013

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Determine safety of outpatient chemotherapy and autotransplants using refrigerated, non‐frozen grafts in persons with multiple sclerosis

Prevalence of the t(11; 14)(q13; q32) immunoglobulin H/CCND1 in Mexican mestizos with multiple myeloma: A single institution experience

Treatment of Persons with Multiple Myeloma in Underprivileged Circumstances: Real-World Data from a Single Institution

Non-alcoholic fatty liver disease and thrombocytopenia IV: its association with granulocytopenia

Up to half of patients diagnosed with chronic lymphocytic leukemia in México may not require treatment

Long-term results of the treatment of Hodgkin’s lymphoma in a resource-constrained setting: Real-world data from a single center

Patient-Reported-Outcomes and Safety of Autologous Stem Cell Transplantation in Multiple Sclerosis: A Single Center Experience with the "Mexican Method" in 1300 Persons

Secondary malignancies after allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning and outpatient conduction

Reduced-intensity stem cell allografting for PNH patients in the eculizumab era: The Mexican experience

IKAROS Gene Deleted B-Cell Acute Lymphoblastic Leukemia in Mexican Mestizos: Observations in Seven Patients and a Short Review of the Literature

Long-Term Results of the Treatment of Adolescents and Adults with Acute Lymphoblastic Leukemia with a Pediatric-Inspired Regimen Delivered on an Outpatient Basis: A Single Institution Experience

Simultaneous romiplostin, eltrombopag, and prednisone were successful in severe thrombocytopenia of Evans syndrome refractory to hydrocortisone, splenectomy, intravenous IgG, and rituximab

In pursuit of the graft-versus-myeloma effect: A single institution experience

ALL-422 Therapy of Childhood Acute Lymphoblastic Leukemia (ALL) in Resource-Poor Geospaces

CML-416 Allogeneic Hematopoietic Stem Cell Transplantation in Chronic Myelogenous Leukemia in the Tyrosine-Kinase Inhibitors Era: A Single Institution Experience

ALL-419 Can Doses of Post-Transplantation Cyclophosphamide in Haploidentical Stem Cell Allografts Be Reduced?

POSTER: ALL-422 Therapy of Childhood Acute Lymphoblastic Leukemia (ALL) in Resource-Poor Geospaces

POSTER: ALL-419 Can Doses of Post-Transplantation Cyclophosphamide in Haploidentical Stem Cell Allografts Be Reduced?

POSTER: CML-416 Allogeneic Hematopoietic Stem Cell Transplantation in Chronic Myelogenous Leukemia in the Tyrosine-Kinase Inhibitors Era: A Single Institution Experience

POOR HEMOPOIETIC STEM CELL MOBILIZERS IN MULTIPLE MYELOMA : A SINGLE INSTITUTION EXPERIENCE

Reporte de la Primera Reunión Nacional de Consenso para la Inmunofenotipificación de Leucemias Agudas

Modifications to the “Classical” Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis: Efficacy and Safety Study of a Less Toxic Approach Which Improves the Neurological Condition. a Mexican Perspective

Subsequent Malignant Neoplasms after Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning and Outpatient Conduction

POOR HEMOPOIETIC STEM CELL MOBILIZERS IN MULTIPLE MYELOMA : A SINGLE INSTITUTION EXPERIENCE

In Pursuit of the Graft Versus Myeloma Effect: A Single Institution Experience

Suchergebnisse filtern